Tomer Natan
Director Financiero/CFO en Quark Pharmaceuticals, Inc. .
Perfil
Tomer Natan currently works at Quark Pharmaceuticals, Inc., as Chief Financial Officer from 2005.
Mr. Natan received his graduate degree from Bar-Ilan University and undergraduate degree from The College of Management Academic Studies.
Cargos activos de Tomer Natan
Empresas | Cargo | Inicio |
---|---|---|
Quark Pharmaceuticals, Inc.
Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Director Financiero/CFO | 01/01/2005 |
Formación de Tomer Natan.
Bar-Ilan University | Graduate Degree |
The College of Management Academic Studies | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Quark Pharmaceuticals, Inc.
Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Tomer Natan